TACE is a standard therapy for unresectable intermediate HCC, especially for patients with Barcelona Clinic Liver Cancer (BCLC) stage B (15). Several studies ...

Transarterial chemoembolization (TACE) is the standard of care for patients with intermediate stage hepatocellular carcinoma. (BCLC B).

15 авг. 2024 г. · TACE, also known as transarterial chemoembolisation, is a minimally-invasive method of administering chemotherapy directly to a liver tumor via a catheter.

Transarterial chemoembolization (TACE) is the standard of care for patients with intermediate stage hepatocellular carcinoma (BCLC B).

The purpose of TACE for patients with HCC is to locally control or shrink the tumor. Several previous studies demonstrated that the repetition of cTACE ...

8 июн. 2023 г. · TACE is an interventional treatment to deliver chemoembolic materials via the tumor-feeding arteries to induce tumor necrosis by selective ischemia and ...

31 авг. 2017 г. · TACE is generally indicated in the setting of unresectable hepatocellular carcinoma. ... The diagnosis of hepatocellular carcinoma has to be ...

15 мар. 2018 г. · Transarterial chemoembolization (TACE), a locoregional therapy (LRT), is widely recommended as first-line treatment for intermediate-stage HCC (BCLC stage B). Benefits of TACE in... · Addressing Limitations of...

6 мая 2024 г. · The goal of TACE in HCC is to locally treat the tumor tissue by transarterial administration of a combination of anticancer/chemotherapeutic ...